Mounjaro and Wegovy are available on the NHS for those who are eligible. Mounjaro is prescribed by GPs in a phased rollout; Wegovy via specialist services.

Mounjaro is on the NHS for type 2 diabetes and, via a phased rollout, for some people with obesity. See the 2026 eligibility criteria and costs.

Compare the UK's top medicated weight-loss programmes. Second Nature, Voy, Juniper, Numan, and Piko compared on evidence, support, and pricing for 2026.

Private Wegovy prescriptions take 1-2 weeks in the UK, vs 9-18 months on the NHS. 7.2 mg produced 20.7% average weight loss in trials.

Get Mounjaro privately in the UK within 2 weeks. Compare costs, NHS vs private access, and learn why support improves weight loss results by ~5%.

Find out who shouldn't take Mounjaro or Wegovy. Learn about contraindications, drug interactions, and medical conditions requiring caution before starting.

Yes, Wegovy and Mounjaro are MHRA-approved and broadly safe. 2024 reviews cleared mental health and thyroid concerns. Side effects ease within weeks.

No, retatrutide isn't on the NHS as of 2026. We explain when it might be, who'll be eligible, and the MHRA-approved alternatives available now.

No, retatrutide isn't legally available to buy in the UK in 2026. We explain why, the risks of online sellers, and MHRA-approved alternatives.

Retatrutide is a new weight-loss injection made by Eli Lilly. The drug leads to an average of 24% weight loss and may be available by 2028.